Use of Uric Acid-Lowering Agents Limits Experimental Cyclosporine Nephropathy

Publisher： Karger

E-ISSN： 1660-2129|120|1|e12-e19

ISSN： 1660-2129

Source： Nephron Experimental Nephrology, Vol.120, Iss.1, 2011-11, pp. : e12-e19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Statin Upregulates the Expression of Klotho, an Anti-Aging Gene, in Experimental Cyclosporine Nephropathy

By  

Nephron Experimental Nephrology, Vol. 120, Iss. 4, 2012-09 ,pp. : e123-e133

Karger

Access to resources Recommend Favorite

Reducing Serum Uric Acid Attenuates TGF-β1-Induced Profibrogenic Progression in Type 2 Diabetic Nephropathy

By  

Nephron Experimental Nephrology, Vol. 121, Iss. 3-4, 2013-01 ,pp. : e109-e121

Karger

Access to resources Recommend Favorite

Angiotensin II Blockade Limits Tubular Protein Overreabsorption and the Consequent Upregulation of Endothelin 1 Gene in Experimental Membranous Nephropathy

By  

Nephron Experimental Nephrology, Vol. 6, Iss. 2, 1998-03 ,pp. : 121-131

Karger

Access to resources Recommend Favorite

Expression of Ammonia Transporters, Rhbg and Rhcg, in Chronic Cyclosporine Nephropathy in Rats

By  

Nephron Experimental Nephrology, Vol. 110, Iss. 2, 2008-09 ,pp. : e49-e58

Karger

Access to resources Recommend Favorite

Recent Insights into Experimental Mouse Models of Diabetic Nephropathy

By  

Nephron Experimental Nephrology, Vol. 104, Iss. 2, 2006-06 ,pp. : e57-e62

Karger

Access to resources Recommend Favorite